FEIBA must not be used in the following situations if therapeutic alternatives to FEIBA are available: Hypersensitivity to the product or any of the components; Disseminated intravascular coagulation (DIC); Acute thrombosis or embolism (including myocardial infarction).
See Warnings and Precautions.